45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
28,154
Insurances with rates
7
CPT / HCPCS codes
14,548
Source MRF
Most expensive procedures (gross)
68403-1100-6
$3,189,700
BOTULISM IMMUNE GLOBULIN, HUMAN 100 MG INTRAVENOUS SOLUTION [182530]
Gross
$3,189,700
J1411
$3,006,000
ETRANACOGENE DEZAPARVOVEC-DRLB 1X10EXP13 GC/ML INTRAVENOUS SUSPENSION [205640]
Gross
$3,006,000
63613000
$1,062,701
HC LISOCABTAGENE MARA CAR POS T CELLS PER THERA DOSE (BREYANZI)
Gross
$1,062,701
63613001
$1,056,625
HC IDECABTAGENE VICLEUCEL CAR POS T CELLS PER THERA DOSE (ABECMA)
Gross
$1,056,625
J2326
$625,000
NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION [185377]
Gross
$625,000
J0225
$596,755
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE [203985]
Gross
$596,755
J9348
$510,218
NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION [198788]
Gross
$510,218
C9293
$414,244
GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION [116024]
Gross
$414,244
J1747
$260,778
SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION [205041]
Gross
$260,778
J1303
$256,160
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [198352]
Gross
$256,160
J0219
$229,111
AVALGLUCOSIDASE ALFA-NGPT 100 MG INTRAVENOUS SOLUTION [201321]
Gross
$229,111
24338-050-08
$211,200
CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT [21672]
Gross
$211,200
Q2043
$184,010
SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION [104852]
Gross
$184,010
J9347
$173,680
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [205419]
Gross
$173,680
J2840
$167,000
SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION [181124]
Gross
$167,000
J9600
$165,699
PORFIMER 75 MG INTRAVENOUS SOLUTION [14472]
Gross
$165,699
90378
$163,154
PALIVIZUMAB 50 MG/0.5 ML INTRAMUSCULAR SOLUTION [108060]
Gross
$163,154
J1429
$160,320
GOLODIRSEN 50 MG/ML INTRAVENOUS SOLUTION [195519]
Gross
$160,320
J1427
$150,701
VILTOLARSEN 50 MG/ML INTRAVENOUS SOLUTION [197819]
Gross
$150,701
J9118
$142,400
CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION [194797]
Gross
$142,400
J9298
$136,943
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [203116]
Gross
$136,943
J0840
$135,999
CROTALIDAE POLYVAL IMMUNE FAB SOLUTION FOR INJECTION [29313]
Gross
$135,999
J9228
$129,274
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [108956]
Gross
$129,274
J0870
$124,675
IMETELSTAT 47 MG INTRAVENOUS SOLUTION [211240]
Gross
$124,675
J9382
$118,750
ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION [213012]
Gross
$118,750
J9359
$117,735
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION [200229]
Gross
$117,735
J1326
$113,920
ZOLBETUXIMAB-CLZB 100 MG INTRAVENOUS SOLUTION [212372]
Gross
$113,920
J0584
$113,560
BUROSUMAB-TWZA 10 MG/ML SUBCUTANEOUS SOLUTION [190441]
Gross
$113,560
J1951
$112,890
LEUPROLIDE 45 MG (PEDIATRIC 6 MONTH) SUBCUTANEOUS SYRINGE [196851]
Gross
$112,890
J9272
$109,499
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [200237]
Gross
$109,499
J9226
$107,419
HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT [170312]
Gross
$107,419
J3241
$99,532
TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION [195813]
Gross
$99,532
J9273
$98,280
TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION [201618]
Gross
$98,280
J9021
$97,678
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN (RYLAZE) 10 MG/0.5ML [40817046]
Gross
$97,678
J0221
$96,860
ALGLUCOSIDASE (LUMIZYME) 50 MG INTRAVENOUS SOLUTION [500225]
Gross
$96,860
J0222
$95,190
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION [191123]
Gross
$95,190
27800520
$93,600
HC 278 WO HCPCS WATCHMAN TRICLIP STEERABLE CATHETER
Gross
$93,600
J9229
$92,461
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN [188201]
Gross
$92,461
C9306
$88,495
TELISOTUZUMAB VEDOTIN-TLLV 20 MG INTRAVENOUS SOLUTION [215660]
Gross
$88,495
81200003
$85,221
HC CADAVER ORGAN ACQUISITION
Gross
$85,221
34400003
$84,210
HC YITRIUM-90 THERAP UP TO 40 MCI
Gross
$84,210
27800451
$84,000
414660 : KIT IMPL PLSE GENRTR SENZA II
Gross
$84,000
J9063
$83,099
MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [205606]
Gross
$83,099
27800521
$81,900
TRICLIP STEERABLE GUID CATH
Gross
$81,900
J2350
$81,250
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [186245]
Gross
$81,250
J9309
$79,923
POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION [193846]
Gross
$79,923
J9266
$79,905
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION [12519]
Gross
$79,905
J9289
$79,232
NIVOLUMAB 600 MG-HYALURONIDASE-NVHY 10,000 UNIT/5 ML SUBCUT SOLUTION [213618]
Gross
$79,232
J9276
$79,158
ZANIDATAMAB-HRII 300 MG INTRAVENOUS SOLUTION [212771]
Gross
$79,158
27800416
$75,000
HC MITRA CLIP G4 SYSTEM & COMPONENTS INCL CLIPS & STEERABLE CATHETER
Gross
$75,000
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 68403-1100-6 | BOTULISM IMMUNE GLOBULIN, HUMAN 100 MG INTRAVENOUS SOLUTION [182530] | $3,189,700 | $3,189,700 | — | — | 0 |
| J1411 | ETRANACOGENE DEZAPARVOVEC-DRLB 1X10EXP13 GC/ML INTRAVENOUS SUSPENSION [205640] | $3,006,000 | $3,006,000 | — | — | 0 |
| 63613000 | HC LISOCABTAGENE MARA CAR POS T CELLS PER THERA DOSE (BREYANZI) | $1,062,701 | $1,062,701 | — | — | 0 |
| 63613001 | HC IDECABTAGENE VICLEUCEL CAR POS T CELLS PER THERA DOSE (ABECMA) | $1,056,625 | $1,056,625 | — | — | 0 |
| J2326 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION [185377] | $625,000 | $625,000 | — | — | 0 |
| J0225 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE [203985] | $596,755 | $596,755 | — | — | 0 |
| J9348 | NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION [198788] | $510,218 | $510,218 | — | — | 0 |
| C9293 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION [116024] | $414,244 | $414,244 | — | — | 0 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION [205041] | $260,778 | $260,778 | — | — | 0 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [198352] | $256,160 | $256,160 | — | — | 0 |
| J0219 | AVALGLUCOSIDASE ALFA-NGPT 100 MG INTRAVENOUS SOLUTION [201321] | $229,111 | $229,111 | — | — | 0 |
| 24338-050-08 | CARMUSTINE IN POLIFEPROSAN 7.7 MG WAFER FOR IMPLANT [21672] | $211,200 | $211,200 | — | — | 0 |
| Q2043 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION [104852] | $184,010 | $184,010 | — | — | 0 |
| J9347 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [205419] | $173,680 | $173,680 | — | — | 0 |
| J2840 | SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION [181124] | $167,000 | $167,000 | — | — | 0 |
| J9600 | PORFIMER 75 MG INTRAVENOUS SOLUTION [14472] | $165,699 | $165,699 | — | — | 0 |
| 90378 | PALIVIZUMAB 50 MG/0.5 ML INTRAMUSCULAR SOLUTION [108060] | $163,154 | $163,154 | — | — | 0 |
| J1429 | GOLODIRSEN 50 MG/ML INTRAVENOUS SOLUTION [195519] | $160,320 | $160,320 | — | — | 0 |
| J1427 | VILTOLARSEN 50 MG/ML INTRAVENOUS SOLUTION [197819] | $150,701 | $150,701 | — | — | 0 |
| J9118 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION [194797] | $142,400 | $142,400 | — | — | 0 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [203116] | $136,943 | $136,943 | — | — | 0 |
| J0840 | CROTALIDAE POLYVAL IMMUNE FAB SOLUTION FOR INJECTION [29313] | $135,999 | $135,999 | — | — | 0 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [108956] | $129,274 | $129,274 | — | — | 0 |
| J0870 | IMETELSTAT 47 MG INTRAVENOUS SOLUTION [211240] | $124,675 | $124,675 | — | — | 0 |
| J9382 | ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION [213012] | $118,750 | $118,750 | — | — | 0 |
| J9359 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION [200229] | $117,735 | $117,735 | — | — | 0 |
| J1326 | ZOLBETUXIMAB-CLZB 100 MG INTRAVENOUS SOLUTION [212372] | $113,920 | $113,920 | — | — | 0 |
| J0584 | BUROSUMAB-TWZA 10 MG/ML SUBCUTANEOUS SOLUTION [190441] | $113,560 | $113,560 | — | — | 0 |
| J1951 | LEUPROLIDE 45 MG (PEDIATRIC 6 MONTH) SUBCUTANEOUS SYRINGE [196851] | $112,890 | $112,890 | — | — | 0 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [200237] | $109,499 | $109,499 | — | — | 0 |
| J9226 | HISTRELIN 50 MG (65 MCG/DAY) IMPLANT KIT [170312] | $107,419 | $107,419 | — | — | 0 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION [195813] | $99,532 | $99,532 | — | — | 0 |
| J9273 | TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION [201618] | $98,280 | $98,280 | — | — | 0 |
| J9021 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN (RYLAZE) 10 MG/0.5ML [40817046] | $97,678 | $97,678 | — | — | 0 |
| J0221 | ALGLUCOSIDASE (LUMIZYME) 50 MG INTRAVENOUS SOLUTION [500225] | $96,860 | $96,860 | — | — | 0 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION [191123] | $95,190 | $95,190 | — | — | 0 |
| 27800520 | HC 278 WO HCPCS WATCHMAN TRICLIP STEERABLE CATHETER | $93,600 | $93,600 | — | — | 0 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN [188201] | $92,461 | $92,461 | — | — | 0 |
| C9306 | TELISOTUZUMAB VEDOTIN-TLLV 20 MG INTRAVENOUS SOLUTION [215660] | $88,495 | $88,495 | — | — | 0 |
| 81200003 | HC CADAVER ORGAN ACQUISITION | $85,221 | $85,221 | — | — | 0 |
| 34400003 | HC YITRIUM-90 THERAP UP TO 40 MCI | $84,210 | $84,210 | — | — | 0 |
| 27800451 | 414660 : KIT IMPL PLSE GENRTR SENZA II | $84,000 | $84,000 | — | — | 0 |
| J9063 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [205606] | $83,099 | $83,099 | — | — | 0 |
| 27800521 | TRICLIP STEERABLE GUID CATH | $81,900 | $81,900 | — | — | 0 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [186245] | $81,250 | $81,250 | — | — | 0 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION [193846] | $79,923 | $79,923 | — | — | 0 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION [12519] | $79,905 | $79,905 | — | — | 0 |
| J9289 | NIVOLUMAB 600 MG-HYALURONIDASE-NVHY 10,000 UNIT/5 ML SUBCUT SOLUTION [213618] | $79,232 | $79,232 | — | — | 0 |
| J9276 | ZANIDATAMAB-HRII 300 MG INTRAVENOUS SOLUTION [212771] | $79,158 | $79,158 | — | — | 0 |
| 27800416 | HC MITRA CLIP G4 SYSTEM & COMPONENTS INCL CLIPS & STEERABLE CATHETER | $75,000 | $75,000 | — | — | 0 |
Showing top 50 of 28,154 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.